{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Ojcb4hdc9q\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/24011\/\">Not\u00edcias e notas sobre sa\u00fade animal de 14 de julho de 2017<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/24011\/embed\/#?secret=Ojcb4hdc9q\" width=\"600\" height=\"338\" title=\"\u201cNot\u00edcias e notas sobre sa\u00fade animal para 14 de julho de 2017\u201d \u2014 Site da Brakke Consulting\" data-secret=\"Ojcb4hdc9q\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"printer friendly *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for July 14, 2017 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news OTC Channel Cancer in Dogs and Cats &ndash; pre-order by July 31 &nbsp; earnings news Krka &nbsp; other news ABS Global ADM Animal Nutrition Bentley&rsquo;s Pet Stuff Ceva Devenish Nutrition Labtec Neogen PetAg Pet Empawrium Pet Things The Veterinary Cooperative Upscience Veterinary Products, Inc. Virbac Yem-Vit &nbsp; *********************************** BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting&rsquo;s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution.&nbsp; If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at adamson.joel@cox.net. &nbsp; www.BrakkeConsulting.com &nbsp; *********************************** COMPANY EARNINGS RELEASES &bull;&nbsp;Krka reported results for the second quarter of 2017. Animal health product sales were EUR 35 million ($40 million), a decline of 6%&nbsp; compared to the comparable prior-year period. (Animal Pharm) &nbsp; &nbsp; ********************************** COMPANY NEWS RELEASES &bull;&nbsp;Virbac announced it has received FDA approval for Zoletil (generic tiletamine HClView Full Post;"}